| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.1 | $0-$5k | 0.00 |
Summary
A vulnerability was found in Cisco IOS XE. It has been classified as critical. This vulnerability affects unknown code of the component Web-based User Interface. This manipulation as part of Request causes Remote Code Execution. The identification of this vulnerability is CVE-2020-3222. The attack needs to be done within the local network. There is no exploit available. Upgrading the affected component is recommended.
Details
A vulnerability was found in Cisco IOS XE (Router Operating System) (unknown version). It has been declared as critical. Affected by this vulnerability is an unknown code block of the component Web-based User Interface. The manipulation as part of a Request leads to a code vulnerability. The CWE definition for the vulnerability is CWE-17. As an impact it is known to affect confidentiality, integrity, and availability. The summary by CVE is:
A vulnerability in the web-based user interface (web UI) of Cisco IOS XE Software could allow an unauthenticated, adjacent attacker to bypass access control restrictions on an affected device. The vulnerability is due to the presence of a proxy service at a specific endpoint of the web UI. An attacker could exploit this vulnerability by connecting to the proxy service. An exploit could allow the attacker to bypass access restrictions on the network by proxying their access request through the management network of the affected device. As the proxy is reached over the management virtual routing and forwarding (VRF), this could reduce the effectiveness of the bypass.
The weakness was shared 06/03/2020 as cisco-sa-webui-unauthprxy-KXXs as confirmed advisory (Website). The advisory is shared at tools.cisco.com. This vulnerability is known as CVE-2020-3222 since 12/12/2019. Access to the local network is required for this attack. The exploitation doesn't need any form of authentication. Neither technical details nor an exploit are publicly available.
Upgrading eliminates this vulnerability.
The entries VDB-156051, VDB-156050, VDB-156048 and VDB-156047 are related to this item. Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Type
Vendor
Name
License
Website
- Vendor: https://www.cisco.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.3VulDB Meta Temp Score: 5.2
VulDB Base Score: 6.3
VulDB Temp Score: 6.0
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 4.3
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: CodeCWE: CWE-17
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Partially
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Timeline
12/12/2019 🔍06/03/2020 🔍
06/04/2020 🔍
10/21/2020 🔍
Sources
Vendor: cisco.comAdvisory: cisco-sa-webui-unauthprxy-KXXs
Status: Confirmed
CVE: CVE-2020-3222 (🔍)
GCVE (CVE): GCVE-0-2020-3222
GCVE (VulDB): GCVE-100-156049
scip Labs: https://www.scip.ch/en/?labs.20150108
See also: 🔍
Entry
Created: 06/04/2020 14:36Updated: 10/21/2020 16:29
Changes: 06/04/2020 14:36 (41), 06/04/2020 14:41 (12), 10/21/2020 16:29 (1)
Complete: 🔍
Cache ID: 216::103
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.

No comments yet. Languages: en.
Please log in to comment.